Analyst Activity – Beaufort Securities Reiterates Speculative Buy on Amryt Pharma PLC (LON:AMYT)

Analyst Ratings For Amryt Pharma PLC (LON:AMYT)

Story continues below

Today, Beaufort Securities reiterated its Speculative Buy rating on Amryt Pharma PLC (LON:AMYT) with a price target of GBX 62.

There are 1 hold rating, 1 buy rating on the stock.

The current consensus rating on Amryt Pharma PLC (LON:AMYT) is Buy (Score: 2.50) with a consensus target price of GBX 61 per share, a potential .

Some recent analyst ratings include

  • 7/26/2017-Beaufort Securities Reiterated Rating of Speculative Buy.
  • 4/24/2017-Stifel Nicolaus Reiterated Rating of Buy.
  • 3/28/2017-Shore Capital Reiterated Rating of house stock.

    Recent Trading Activity for Amryt Pharma PLC (LON:AMYT)
    Shares of Amryt Pharma PLC closed the previous trading session at 22.80 up +0.05 0.22% with 0 shares trading hands.

    An ad to help with our costs